Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App 
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy 
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal 
How Marco Pharma International Preserves German Homeopathic Traditions in America 
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims 
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed 
MELBOURNE, Fla., April 11, 2018 -- Since 2003, National Association of Professional Background Screeners (NAPBS) has represented the interest of companies offering employment and tenant background screening services. This spring, NAPBS will hold it’s 2018 Mid-Year Legislative & Regulatory Conference. This conference focuses on regulation, legislation, education, and compliance related to the background screening industry. National Drug Screening’s Tom Fulmer will facilitate a break out session during the April 15-17 event in Washington, DC.
|
|||||
The session, titled “Surviving the Shifts: The Changing Face of Engagement” will focus on the dynamic and quickly changing business aspects of the drug and background screening service industry. Mr. Fulmer cited that he is “excited to have been invited to present this break out session among leaders in the industry.” Mr. Fulmer’s presentation will provide value for all those who attend. He continues, “There’s something for everyone in this breakout session. Whether you are new to the drug testing and screening world or an industry veteran, there will be valuable takeaways.”
In his position as Vice President of Business Development at National Drug Screening, Mr. Fulmer helps companies reduce and manage risk and exposure within their work environments by providing drug testing solutions, MRO services, supervisor, collector & DER training, and program support & management services for employers and other drug testing companies.
Registration for the NAPBS 2018 Mid -Year Legislative & Regulatory Conference is currently open. More information can be found at the NAPBS website.
About National Drug Screening, Inc: Located on the east coast of Central Florida, National Drug Screening, Inc. offers nationwide service for drug test result reporting by state of the art MRO services, drug testing software, immediate drug tests, drug & alcohol testing for employees. NDS specializes in Drug Screening, Immediate Testing, Drug-Free Workplace programs, DOT Compliance, Employer Programs, and customized Employer Drug Screening Programs.
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/08920b7d-0a0f-4e21-b2ca-176de5211f36
Joe Reilly
National Drug Screening, Inc
866-843-4545
[email protected]
www.nationaldrugscreening.com
